Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ambar Qavi"'
Autor:
Michael Bahrami-Hessari, Emma Smith, Katherine Baker, Halle Johnson, Carmel McGrath, Ambar Qavi, Robert C. Read, Christopher Chiu, Caroline Barker, Helen Ward, Diane Gbesemete, Katharine Collet, Daniella Watson, Maria Piggin, Wendy Lawerence, Philippa Pristerà
Publikováno v:
Wellcome Open Research, Vol 7 (2022)
Background: Human challenge studies involve the deliberate exposure of healthy volunteers to an infectious micro-organism in a highly controlled and monitored way. They are used to understand infectious diseases and have contributed to the developmen
Externí odkaz:
https://doaj.org/article/1890fc4d0290465c8defdad24849683c
Autor:
Bronwyn Bosch, Godspower Akpomiemie, Nomathemba Chandiwana, Simiso Sokhela, Andrew Hill, Kaitlyn McCann, Ambar Qavi, Manya Mirchandani, Willem Daniel Francois Venter
Publikováno v:
Clinical Infectious Diseases. 76:1492-1495
Participants randomized to first-line tenofovir alafenamide (TAF)/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC + DTG, or TDF/FTC/efavirenz (EFV) for 192 weeks were then switched to TDF/lamivudine (3TC)/DTG for 52 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3646bc55c6d97f3b0b0fded95e10fec4
https://doi.org/10.1093/cid/ciac949
https://doi.org/10.1093/cid/ciac949
Autor:
Anthony C. Gordon, Anupop Jitmuang, Timothy B. Hallett, Graham S Cooke, Adhiratha Boonyasiri, Ester Cerdeira Sabino, Hayley A Thompson, Pratthana Srisangthong, Maria Eugenia Grillet, Zarir F Udwadia, Shevanthi Nayagam, Lantharita Charoenpong, Diana M. Gibb, Andrew N. Phillips, Sorawat Sangkaew, Djayanti Sari, Carlos Alvarez-Moreno, Gustavo Lopardo, Azra C. Ghani, Patrick G T Walker, Panuwat Promsin, Bimandra A Djaafara, Ng’ang’a Irene Hannah Njeri, Anna S. Levin, Zulma M. Cucunubá, Cássia Fernanda Estofolete, Oliver J Watson, Nuno R. Faria, Maurício Lacerda Nogueira, Charles Whittaker, Methee Chayakulkeeree, Raph L. Hamers, Arran Hamlet, Nasikarn Angkasekwinai, Luis Carlos Triana, Teresia Njoki Kimani, Thundon Ngamprasertchai, Mauricio W. Perroud, Vera Irawany, Julio Croda, Silvia Figueiredo Costa, Rujipas Sirijatuphat, David A Forero-Peña, Margarita Lampo, Ambar Qavi, Nukool Keurueangkul, Alison Rodger, Peter Winskill, Rima Mustafa, Esteban Ortiz-Prado, Duncan Chanda, Sandra Valderrama-Beltrán, Andrei C. Sposito
Publikováno v:
Clinical infectious diseases, 75(1), E224-E233. Oxford University Press
Background The public health impact of the coronavirus disease 2019 (COVID-19) pandemic has motivated a rapid search for potential therapeutics, with some key successes. However, the potential impact of different treatments, and consequently research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7140c4c5339efe11e8fb279d2798fa5
https://doi.org/10.1093/cid/ciab837
https://doi.org/10.1093/cid/ciab837
Autor:
Bronwyn, Bosch, Godspower, Akpomiemie, Nomathemba, Chandiwana, Simiso, Sokhela, Andrew, Hill, Kaitlyn, McCann, Ambar, Qavi, Manya, Mirchandani, Willem Daniel Francois, Venter
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Participants randomised to first-line tenofovir alafenamide (TAF)/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG or TDF/FTC/efavirenz (EFV) for 192 weeks were then switched to TDF/lamivudine (3TC)/DTG for 52 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68deecd2847eef5502cb0a1ec83c421b
https://pubmed.ncbi.nlm.nih.gov/36519389
https://pubmed.ncbi.nlm.nih.gov/36519389
Autor:
Celicia Serenata, Polly Clayden, Toby Pepperrell, Kenly Sikwese, Ambar Qavi, Meg Doherty, Martina Penazzato, Luckyboy Mkhondwane, W D Francois Venter, Andrew Hill, Marco Vitoria
Publikováno v:
AIDS. 35:S113-S115
Progression in the development of antiretroviral therapy has been remarkable, with new agents continuing to appear as options for modern regimens, including in low-and-middle income countries where the HIV epidemic is concentrated. Here, we reflect o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0626df2a9cb531779b65963cf16f4c
https://doi.org/10.1097/qad.0000000000003081
https://doi.org/10.1097/qad.0000000000003081
Autor:
Simiso Sokhela, Bronwyn Bosch, Andrew Hill, Bryony Simmons, Joana Woods, Hilary Johnstone, Shabir Madhi, Ambar Qavi, Leah Ellis, Godspower Akpomiemie, Esther Bhaskar, Jacob Levi, Jonathan Falconer, Manya Mirchandani, Carmen Perez Casas, Karlien Moller, Victoria Pilkington, Toby Pepperrell, Willem Daniel Francois Venter
Publikováno v:
Open forum infectious diseases. 9(12)
In high-risk individuals in Johannesburg, during the Delta coronavirus disease 2019 wave, 22% (125/561) were positive, with 33% symptomatic (2 hospitalizations; 1 death). During Omicron, 56% (232/411) were infected, with 24% symptomatic (no hospitali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5271d312eeebb4130cacd3c2d84a3345
https://pubmed.ncbi.nlm.nih.gov/36540387
https://pubmed.ncbi.nlm.nih.gov/36540387
Autor:
Nomathemba Chandiwana, Natasha Arulappan, Matthew Chersich, Bryony Simmons, Masebole Masenya, Michelle Moorhouse, Shane A. Norris, Polly Clayden, Ambar Qavi, Simiso Sokhela, Willem D F Venter, Celicia Serenata, Elaine J. Abrams, Godspower Akpomiemie, Kaitlyn McCann, Nkuli Mashabane, Samanta T. Lalla-Edward, Lee Fairlie, Andrew Hill, Gary Maartens, Alinda G. Vos
Publikováno v:
The Lancet HIV. 7:e666-e676
ADVANCE compared the efficacy and safety of two antiretroviral first-line combinations (dolutegravir combined with emtricitabine and either tenofovir disoproxil fumarate or tenofovir alafenamide), with a third regimen (efavirenz combined with emtrici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d05d0fad98edf7ad40a319200d5374a
https://doi.org/10.1016/s2352-3018(20)30241-1
https://doi.org/10.1016/s2352-3018(20)30241-1
Autor:
Anna Garratt, Jacob Levi, Amir H. Davarpanah, Hannah Wentzel, Zahedin Kheiri, Ali Ali Asgari, Shirin Afhami, Andrew Hill, Amir Anushirvani, Ambar Qavi, Anahita Sadeghi, Hadiseh Hosamirudsai, Rasoul Aliannejad, Bryony Simmons, Shahin Merat, Mahnaz Montazeri, Elham Akbarpour, Alireza Norouzi, Amir Reza Radmard
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5e5e65393785b51570902cb135294dd
https://doi.org/10.1093/jac/dkaa334
https://doi.org/10.1093/jac/dkaa334
Autor:
Charles Whittaker, Hayley A Thompson, Lantharita Charoenpong, Alison Rodger, Ambar Qavi, Sandra Valderrama-Beltrán, Djayanti Sari, Bimandra A. Djafaara, Teresia Njoki Kimani, Nuno R. Faria, Panuwat Promsin, Anthony C. Gordon, Anupop Jitmuang, Nukool Keurueangkul, Pratthana Srisangthong, Ester Cerdeira Sabino, Zulma Cucunuba, Maurício Lacerda Nogueira, Andrei C. Sposito, Thundon Ngamprasertchai, Rima Mustafa, Rujipas Sirijatuphat, Luis Carlos-Triana, Timothy B. Hallett, Raph L. Hamers, Gustavo Lopardo, Peter Winskill, Sorawat Sangkaew, Cássia Fernanda Estofolete, Oliver J Watson, Diana M. Gibb, Methee Chayakulkeeree, Andrew N. Phillips, Zarir Udwadia, Mauricio W. Perroud, Graham S Cooke, David A Forero-Peña, Vera Irawany, Adhiratha Boonyasiri, Ng’ang’a Irene Hannah Njeri, Anna S. Levin, Julio Croda, Shevanthi Nayagam, Nasikarn Angkasekwinai, Carlos Alvarez-Moreno, Azra C. Ghani, Patrick G T Walker, Arran Hamlet, Margarita Lampo, Maria Eugenia-Grillet, Duncan Chanda, Esteban Ortiz-Prado, Silva Figueiredo-Costa
Publikováno v:
e233
e224
e224
BackgroundThe unprecedented public health impact of the COVID-19 pandemic has motivated a rapid search for potential therapeutics, with some key successes. However, the potential impact of different treatments, and consequently research and procureme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd1a5dd9ec5ab5b8daa28191af1ffc6d
http://hdl.handle.net/10044/1/91886
http://hdl.handle.net/10044/1/91886
Autor:
Kaitlyn McCann, Jonathan Falconer, Anna Garratt, Jacob Levi, Hannah Wentzel, Junzheng Wang, Victoria Pilkington, Andrew Hill, Ambar Qavi, Leah Ellis
Publikováno v:
Open Forum Infectious Diseases. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c92cc3a113bdbb16abf633c1d172c8f
https://doi.org/10.1093/ofid/ofab394
https://doi.org/10.1093/ofid/ofab394